Huang Weixin, Li Xiaohui, Wang Yuanping, Yan Xia, Wu Siping
The Second Affiliated Hospital of Guangzhou University of Chinese Medicine The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
Medicine (Baltimore). 2017 Dec;96(49):e9110. doi: 10.1097/MD.0000000000009110.
Stress urinary incontinence (SUI) is a widespread complaint in the adult women. Electroacupuncture has been widely applied in the treatment of SUI. But its efficacy has not been evaluated scientifically and systematically. Therefore, we provide a protocol of systematic evaluation to assess the effectiveness and safety of electroacupuncture treatment on women with SUI.
The retrieved databases include 3 English literature databases, namely PubMed, Embase, and Cochrane Library, and 3 Chinese literature databases, namely Chinese Biomedical Literature Database (CBM), China National Knowledge Infrastructure (CNKI), and Wanfang Database. The randomized controlled trials (RCTs) of the electroacupuncture treatment on women with SUI will be searched in the above-mentioned databases from the time when the respective databases were established to December 2017. The change from baseline in the amount of urine leakage measured by the 1-hour pad test will be accepted as the primary outcomes. We will use RevMan V.5.3 software as well to compute the data synthesis carefully when a meta-analysis is allowed.
This study will provide a high-quality synthesis to assess the effectiveness and safety of electroacupuncture treatment on women with SUI.
The conclusion of our systematic review will provide evidence to judge whether electroacupuncture is an effective intervention for women with SUI.
PROSPERO CRD42017070947.
压力性尿失禁(SUI)是成年女性中普遍存在的问题。电针已广泛应用于SUI的治疗。但其疗效尚未得到科学系统的评估。因此,我们提供一项系统评价方案,以评估电针治疗女性SUI的有效性和安全性。
检索的数据库包括3个英文文献数据库,即PubMed、Embase和Cochrane图书馆,以及3个中文文献数据库,即中国生物医学文献数据库(CBM)、中国知网(CNKI)和万方数据库。将从各数据库建立之时至2017年12月在上述数据库中检索电针治疗女性SUI的随机对照试验(RCT)。以1小时护垫试验测量的漏尿量相对于基线的变化作为主要结局指标。当允许进行荟萃分析时,我们还将使用RevMan V.5.3软件仔细计算数据合并。
本研究将提供高质量的综合分析,以评估电针治疗女性SUI的有效性和安全性。
我们系统评价的结论将为判断电针是否为女性SUI的有效干预措施提供证据。
PROSPERO注册号:PROSPERO CRD42017070947。